Improving treatment choices for recurrent bladder cancer
BEST CARE for Recurrent NMIBC: BladdEr-Sparing Therapy and Cystectomy As TREatments
This project helps patients with recurrent bladder cancer and their doctors make better decisions about whether to remove the bladder or try other treatments.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Washington NIH-funded |
| Lab location | 1 site (Seattle, United States) |
| Project ID | NIH-11082335 on NIH RePORTER |
What this research studies
Many people with bladder cancer experience it coming back, which is called recurrent non-muscle invasive bladder cancer (NMIBC). When this happens, patients and their doctors face a difficult choice between treatments that save the bladder but might not fully remove the cancer, or a major surgery to remove the bladder entirely. Currently, there isn't enough clear information to guide this important decision. This project will use information from a large group of patients to understand the best ways to treat recurrent bladder cancer and improve outcomes.
Who could benefit from this research
Good fit: This project is relevant for patients diagnosed with recurrent high-grade non-muscle invasive bladder cancer who are considering treatment options.
Not a fit: Patients with other types of cancer or those who have not experienced recurrent bladder cancer may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could provide clearer guidance for patients and doctors, leading to more informed and personalized treatment decisions for recurrent bladder cancer.
How similar studies have performed: This project builds upon an existing patient cohort (CISTO Study) to address critical evidence gaps in bladder cancer treatment, suggesting a foundation of prior data collection.
Where this research is happening
Seattle, United States
- University of Washington — Seattle, United States (Active)
Researchers
- Principal investigator: Gore, John L. — University of Washington
- Study coordinator: Gore, John L.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.